Drug intelligence / Profile preview

Alginos

Development stage
Phase 4
Lead developer
TTY Biopharm
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Oral
01

Overview

Alginos is an oral suspension containing sodium alginate (50 mg/ml) developed by TTY Biopharm. It is being investigated for the treatment of Laryngopharyngeal Reflux (LPR), a condition characterized by the backflow of gastric acid into the larynx and hypopharynx, leading to symptoms like hoarseness and throat pain. Sodium alginate is known for its effectiveness in the symptomatic treatment of gastroesophageal reflux, where it forms a protective raft on the gastric contents to prevent reflux. The ongoing clinical study aims to evaluate the efficacy and safety of Alginos in LPR patients.

Brand names
Alginos
Other names
Sodium alginate oral suspension

Beyond the preview

Go deeper on Alginos.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alginos.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call